ProfileGDS4132 / 232703_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 40% 37% 37% 41% 37% 34% 38% 33% 34% 42% 39% 39% 40% 34% 41% 48% 34% 40% 46% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101105.61740
GSM201543Muscle PCOS pioglitazone 12184.945437
GSM201544Muscle PCOS pioglitazone 16195.724837
GSM201545Muscle PCOS pioglitazone 201115.2141
GSM201829Muscle PCOS pioglitazone 23110137
GSM201830Muscle PCOS pioglitazon 25189.092834
GSM201831Muscle PCOS pioglitazone 27198.424638
GSM201832Muscle PCOS pioglitazone 3184.245933
GSM201833Muscle PCOS pioglitazone 4180.597534
GSM201834Muscle PCOS pioglitazone 81107.09942
GSM201835Muscle PCOS after pioglitazone 10286.945239
GSM201836Muscle PCOS after pioglitazone 12289.042239
GSM201837Muscle PCOS after pioglitazone 16288.820140
GSM201838Muscle PCOS after pioglitazone 20277.409234
GSM201839Muscle PCOS after pioglitazone 232100.02941
GSM201840Muscle PCOS after pioglitazone 252123.02448
GSM201841Muscle PCOS after pioglitazone 27272.242534
GSM201842Muscle PCOS after pioglitazone 3284.791740
GSM201843Muscle PCOS after pioglitazone 42115.6446
GSM201844Muscle PCOS after pioglitazone 8298.5140